Concepts (278)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 11 | 2023 | 489 | 3.320 |
Why?
|
| Obesity, Morbid | 10 | 2023 | 186 | 3.220 |
Why?
|
| Bariatric Surgery | 7 | 2023 | 117 | 2.070 |
Why?
|
| Pediatric Obesity | 6 | 2023 | 385 | 1.830 |
Why?
|
| Esophageal Atresia | 4 | 2024 | 51 | 1.410 |
Why?
|
| Moyamoya Disease | 3 | 2022 | 38 | 1.350 |
Why?
|
| Cerebral Revascularization | 3 | 2022 | 21 | 1.300 |
Why?
|
| Gastrectomy | 6 | 2023 | 90 | 1.050 |
Why?
|
| Communication Barriers | 2 | 2015 | 39 | 0.950 |
Why?
|
| Funnel Chest | 1 | 2024 | 34 | 0.860 |
Why?
|
| Omentum | 3 | 2022 | 47 | 0.800 |
Why?
|
| Patient Satisfaction | 2 | 2015 | 476 | 0.750 |
Why?
|
| Physician-Patient Relations | 2 | 2015 | 426 | 0.750 |
Why?
|
| Gastroschisis | 3 | 2017 | 53 | 0.720 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2024 | 200 | 0.700 |
Why?
|
| Endoscopy | 2 | 2024 | 284 | 0.700 |
Why?
|
| Sutures | 2 | 2017 | 67 | 0.640 |
Why?
|
| Respiratory System Abnormalities | 1 | 2018 | 42 | 0.600 |
Why?
|
| Surgical Flaps | 2 | 2022 | 204 | 0.600 |
Why?
|
| Pilomatrixoma | 1 | 2018 | 5 | 0.600 |
Why?
|
| Hair Diseases | 1 | 2018 | 14 | 0.600 |
Why?
|
| Pancreatic Neoplasms | 3 | 2009 | 685 | 0.590 |
Why?
|
| Facial Neoplasms | 1 | 2018 | 19 | 0.590 |
Why?
|
| Hirschsprung Disease | 1 | 2017 | 35 | 0.580 |
Why?
|
| Retrospective Studies | 21 | 2023 | 16223 | 0.580 |
Why?
|
| Hernia, Inguinal | 2 | 2015 | 41 | 0.580 |
Why?
|
| Dermoid Cyst | 1 | 2018 | 34 | 0.570 |
Why?
|
| Ileostomy | 1 | 2017 | 31 | 0.570 |
Why?
|
| Herniorrhaphy | 2 | 2015 | 81 | 0.560 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2017 | 7 | 0.560 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 83 | 0.550 |
Why?
|
| Suture Techniques | 2 | 2015 | 198 | 0.550 |
Why?
|
| Adolescent | 22 | 2023 | 19353 | 0.540 |
Why?
|
| Tracheoesophageal Fistula | 3 | 2023 | 48 | 0.540 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 267 | 0.540 |
Why?
|
| Language | 2 | 2015 | 204 | 0.530 |
Why?
|
| Surgical Procedures, Operative | 2 | 2015 | 181 | 0.520 |
Why?
|
| Birth Weight | 2 | 2017 | 348 | 0.520 |
Why?
|
| Ligation | 2 | 2015 | 135 | 0.510 |
Why?
|
| Treatment Outcome | 19 | 2023 | 12279 | 0.500 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 40 | 0.490 |
Why?
|
| Intestine, Small | 1 | 2017 | 313 | 0.480 |
Why?
|
| Culturally Competent Care | 1 | 2015 | 45 | 0.480 |
Why?
|
| Lung Diseases | 1 | 2018 | 383 | 0.480 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 397 | 0.460 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1061 | 0.430 |
Why?
|
| Humans | 47 | 2024 | 124332 | 0.430 |
Why?
|
| Venous Cutdown | 1 | 2013 | 2 | 0.430 |
Why?
|
| General Surgery | 1 | 2015 | 204 | 0.430 |
Why?
|
| Choledochal Cyst | 1 | 2013 | 8 | 0.420 |
Why?
|
| Jugular Veins | 1 | 2013 | 76 | 0.410 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2013 | 95 | 0.400 |
Why?
|
| Liver | 1 | 2020 | 1760 | 0.400 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2087 | 0.390 |
Why?
|
| Gastric Bypass | 2 | 2023 | 70 | 0.390 |
Why?
|
| Lung | 2 | 2019 | 1483 | 0.380 |
Why?
|
| Male | 28 | 2023 | 60988 | 0.380 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 134 | 0.380 |
Why?
|
| Splenectomy | 1 | 2011 | 64 | 0.370 |
Why?
|
| Child | 19 | 2024 | 24515 | 0.370 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 3576 | 0.350 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 803 | 0.350 |
Why?
|
| Body Mass Index | 4 | 2023 | 1550 | 0.350 |
Why?
|
| Female | 29 | 2023 | 66265 | 0.330 |
Why?
|
| Infant, Newborn | 8 | 2019 | 8184 | 0.330 |
Why?
|
| Pediatrics | 2 | 2015 | 1160 | 0.320 |
Why?
|
| Weight Loss | 3 | 2023 | 482 | 0.310 |
Why?
|
| Infant | 9 | 2022 | 12476 | 0.310 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2009 | 73 | 0.310 |
Why?
|
| Neuroendocrine Tumors | 1 | 2009 | 53 | 0.300 |
Why?
|
| Splenic Vein | 1 | 2008 | 10 | 0.300 |
Why?
|
| Physicians | 1 | 2014 | 579 | 0.300 |
Why?
|
| Splenic Artery | 1 | 2008 | 26 | 0.300 |
Why?
|
| Short Bowel Syndrome | 1 | 2008 | 64 | 0.290 |
Why?
|
| Pancreatectomy | 1 | 2008 | 137 | 0.280 |
Why?
|
| Spleen | 1 | 2008 | 280 | 0.280 |
Why?
|
| Laparotomy | 1 | 2008 | 135 | 0.280 |
Why?
|
| Parenteral Nutrition | 1 | 2008 | 194 | 0.270 |
Why?
|
| Ultrasonography | 3 | 2017 | 928 | 0.270 |
Why?
|
| Neuroblastoma | 2 | 2022 | 520 | 0.260 |
Why?
|
| Child, Preschool | 12 | 2022 | 14076 | 0.250 |
Why?
|
| Follow-Up Studies | 7 | 2023 | 5106 | 0.250 |
Why?
|
| Appendicitis | 2 | 2017 | 128 | 0.240 |
Why?
|
| Intestines | 1 | 2008 | 573 | 0.230 |
Why?
|
| Prospective Studies | 6 | 2021 | 6084 | 0.230 |
Why?
|
| Magnets | 1 | 2024 | 22 | 0.220 |
Why?
|
| Fluoroscopy | 1 | 2024 | 92 | 0.220 |
Why?
|
| Intestinal Atresia | 2 | 2017 | 19 | 0.220 |
Why?
|
| Acetates | 1 | 2023 | 71 | 0.210 |
Why?
|
| Postoperative Complications | 6 | 2023 | 3062 | 0.210 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2022 | 12 | 0.210 |
Why?
|
| Esophagoplasty | 1 | 2022 | 12 | 0.200 |
Why?
|
| Leiomyomatosis | 1 | 2022 | 7 | 0.200 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2022 | 8 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1241 | 0.200 |
Why?
|
| Rectal Fistula | 1 | 2021 | 4 | 0.190 |
Why?
|
| Anus, Imperforate | 1 | 2021 | 20 | 0.190 |
Why?
|
| Urethral Diseases | 1 | 2021 | 17 | 0.190 |
Why?
|
| Urinary Fistula | 1 | 2021 | 20 | 0.190 |
Why?
|
| Diverticulum | 1 | 2021 | 28 | 0.180 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2021 | 45 | 0.180 |
Why?
|
| Intraoperative Period | 1 | 2020 | 75 | 0.170 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2019 | 20 | 0.170 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 86 | 0.160 |
Why?
|
| Intraoperative Care | 1 | 2020 | 104 | 0.160 |
Why?
|
| Telomerase | 1 | 2020 | 160 | 0.160 |
Why?
|
| Cerebellar Neoplasms | 1 | 2022 | 285 | 0.160 |
Why?
|
| Preoperative Period | 1 | 2018 | 87 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 1319 | 0.150 |
Why?
|
| Medulloblastoma | 1 | 2022 | 340 | 0.150 |
Why?
|
| Eyebrows | 1 | 2018 | 13 | 0.150 |
Why?
|
| Forehead | 1 | 2018 | 13 | 0.150 |
Why?
|
| Young Adult | 7 | 2021 | 8978 | 0.150 |
Why?
|
| Epidermal Cyst | 1 | 2018 | 19 | 0.150 |
Why?
|
| Dyslipidemias | 1 | 2021 | 229 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2021 | 1400 | 0.150 |
Why?
|
| Patient Care Planning | 1 | 2018 | 122 | 0.140 |
Why?
|
| Pneumonectomy | 1 | 2018 | 129 | 0.140 |
Why?
|
| Pylorus | 1 | 2017 | 21 | 0.140 |
Why?
|
| Prenatal Care | 1 | 2019 | 348 | 0.140 |
Why?
|
| Fundoplication | 1 | 2017 | 66 | 0.130 |
Why?
|
| Cicatrix | 1 | 2018 | 123 | 0.130 |
Why?
|
| Prevalence | 2 | 2021 | 2428 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 2030 | 0.130 |
Why?
|
| Diaphragm | 1 | 2017 | 98 | 0.130 |
Why?
|
| Telemedicine | 1 | 2022 | 434 | 0.130 |
Why?
|
| Patient Selection | 1 | 2020 | 688 | 0.130 |
Why?
|
| Biopsy | 1 | 2020 | 1237 | 0.130 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2016 | 25 | 0.130 |
Why?
|
| Gestational Age | 2 | 2017 | 1161 | 0.130 |
Why?
|
| Dissection | 1 | 2016 | 53 | 0.130 |
Why?
|
| Time Factors | 3 | 2021 | 6262 | 0.130 |
Why?
|
| Testicular Hydrocele | 1 | 2015 | 3 | 0.130 |
Why?
|
| Gastroscopy | 1 | 2016 | 102 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 645 | 0.120 |
Why?
|
| California | 1 | 2015 | 128 | 0.120 |
Why?
|
| Hamartoma | 1 | 2016 | 52 | 0.120 |
Why?
|
| Gastric Fistula | 1 | 2014 | 5 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2020 | 4730 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 673 | 0.120 |
Why?
|
| Angiography | 1 | 2015 | 217 | 0.120 |
Why?
|
| Home Childbirth | 1 | 2015 | 39 | 0.120 |
Why?
|
| Quality Improvement | 2 | 2023 | 639 | 0.120 |
Why?
|
| Maternal Age | 1 | 2015 | 132 | 0.120 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 97 | 0.120 |
Why?
|
| Cutaneous Fistula | 1 | 2014 | 22 | 0.120 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 105 | 0.120 |
Why?
|
| United States | 4 | 2021 | 10767 | 0.120 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 330 | 0.120 |
Why?
|
| Hematoma | 1 | 2015 | 92 | 0.120 |
Why?
|
| Health Care Surveys | 1 | 2015 | 286 | 0.120 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 597 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2122 | 0.110 |
Why?
|
| Infant Mortality | 1 | 2015 | 173 | 0.110 |
Why?
|
| Gastrostomy | 1 | 2014 | 84 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2018 | 683 | 0.110 |
Why?
|
| Adult | 9 | 2021 | 29378 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 78 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 645 | 0.110 |
Why?
|
| Developing Countries | 1 | 2015 | 268 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 6467 | 0.100 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 243 | 0.100 |
Why?
|
| Middle Aged | 5 | 2021 | 26442 | 0.100 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 485 | 0.100 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 257 | 0.100 |
Why?
|
| Anastomosis, Surgical | 2 | 2023 | 168 | 0.100 |
Why?
|
| Thoracic Neoplasms | 1 | 2012 | 36 | 0.100 |
Why?
|
| Hypertension | 1 | 2021 | 1282 | 0.100 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2017 | 402 | 0.100 |
Why?
|
| Thoracic Wall | 1 | 2012 | 36 | 0.100 |
Why?
|
| Obesity | 2 | 2021 | 2250 | 0.100 |
Why?
|
| Surgical Mesh | 1 | 2012 | 62 | 0.100 |
Why?
|
| Umbilicus | 1 | 2011 | 13 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 123 | 0.100 |
Why?
|
| Wound Healing | 1 | 2015 | 456 | 0.090 |
Why?
|
| Recurrence | 1 | 2015 | 1423 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 307 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 314 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1674 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2015 | 815 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2020 | 2607 | 0.080 |
Why?
|
| Pregnancy | 2 | 2019 | 7166 | 0.080 |
Why?
|
| Enterostomy | 1 | 2008 | 5 | 0.080 |
Why?
|
| Nebraska | 1 | 2008 | 1 | 0.080 |
Why?
|
| Intestinal Volvulus | 1 | 2008 | 38 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2008 | 124 | 0.070 |
Why?
|
| Length of Stay | 2 | 2014 | 1307 | 0.070 |
Why?
|
| Age of Onset | 1 | 2008 | 582 | 0.070 |
Why?
|
| Diphosphonates | 1 | 2006 | 38 | 0.070 |
Why?
|
| Disabled Children | 1 | 2006 | 25 | 0.070 |
Why?
|
| Aged | 3 | 2009 | 19460 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 54 | 0.060 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 52 | 0.060 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2008 | 242 | 0.060 |
Why?
|
| Carotid Stenosis | 1 | 2006 | 138 | 0.060 |
Why?
|
| Cerebral Palsy | 1 | 2006 | 80 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 370 | 0.060 |
Why?
|
| Adrenal Gland Diseases | 1 | 2004 | 13 | 0.060 |
Why?
|
| Emergency Service, Hospital | 3 | 2017 | 1088 | 0.060 |
Why?
|
| Compassionate Use Trials | 1 | 2023 | 14 | 0.050 |
Why?
|
| Cysts | 1 | 2004 | 101 | 0.050 |
Why?
|
| Accreditation | 1 | 2023 | 83 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2022 | 75 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2022 | 151 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 51 | 0.050 |
Why?
|
| Nutrition Disorders | 1 | 2021 | 32 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2004 | 463 | 0.050 |
Why?
|
| Incidence | 1 | 2008 | 3086 | 0.040 |
Why?
|
| Remission Induction | 1 | 2021 | 301 | 0.040 |
Why?
|
| Indolizines | 1 | 2020 | 3 | 0.040 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2020 | 3 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 2020 | 21 | 0.040 |
Why?
|
| Stents | 1 | 2006 | 884 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 30 | 0.040 |
Why?
|
| Reoperation | 2 | 2014 | 830 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 72 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 39 | 0.040 |
Why?
|
| Pyridazines | 1 | 2020 | 51 | 0.040 |
Why?
|
| Risk Factors | 2 | 2015 | 10139 | 0.040 |
Why?
|
| Stroke | 1 | 2006 | 974 | 0.040 |
Why?
|
| Inpatients | 1 | 2022 | 496 | 0.040 |
Why?
|
| Piperazines | 1 | 2020 | 233 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2020 | 325 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 305 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2022 | 820 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 862 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 887 | 0.030 |
Why?
|
| Chromatin | 1 | 2020 | 554 | 0.030 |
Why?
|
| Histones | 1 | 2020 | 534 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 1341 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1514 | 0.030 |
Why?
|
| Zimbabwe | 1 | 2015 | 10 | 0.030 |
Why?
|
| Mozambique | 1 | 2015 | 17 | 0.030 |
Why?
|
| Surgery Department, Hospital | 1 | 2015 | 20 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1102 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2805 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2016 | 306 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 166 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 963 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 106 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 102 | 0.030 |
Why?
|
| Neoplasms | 1 | 2008 | 2795 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 359 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 936 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 775 | 0.030 |
Why?
|
| Stomach | 1 | 2016 | 273 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 152 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1417 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 597 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 3342 | 0.030 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2012 | 18 | 0.030 |
Why?
|
| Sarcoma, Synovial | 1 | 2012 | 21 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 1900 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1804 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2014 | 258 | 0.020 |
Why?
|
| Sarcoma, Ewing | 1 | 2012 | 117 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 1949 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1264 | 0.020 |
Why?
|
| Premature Birth | 1 | 2015 | 384 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2015 | 495 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 433 | 0.020 |
Why?
|
| Scoliosis | 1 | 2012 | 134 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 214 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4554 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3371 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 430 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4532 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2006 | 26 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 548 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2006 | 169 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2006 | 193 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2006 | 187 | 0.010 |
Why?
|
| Bone Density | 1 | 2006 | 319 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 17722 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1687 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 3003 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 34134 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 2896 | 0.010 |
Why?
|